story of the week
Ibrutinib Regimens vs Chemoimmunotherapy in Older Patients With Untreated Chronic Lymphocytic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine